Potential for Improved Glycemic Control with Dietary Momordica charantia in Patients with Insulin Resistance and Pre-Diabetes

International Journal of Environmental Research and Public Health

Jimmy T. Efird¹  Yuk Ming Choi⁴  Stephen W. Davies³  Sanjay Mehra⁵  Ethan J. Anderson² 

[1] East Carolina Heart Institute and the Center for Health Disparities, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA;Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA; E-Mails:;Department of General Surgery, University of Virginia School of Medicine, Charlottesville, VA 22908, USA; E-Mail:;Adult Gerontological Nurse Practitioner Program, School of Nursing, University of North Carolina at Greensboro, Greensboro, NC 27402, USA; E-Mail:;Department of Cardiovascular Sciences, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA; E-Mail:

关键词: Momordica charantia;    bitter melon;    insulin resistance;    pre-diabetes;    glycemic control;   

DOI  :  10.3390/ijerph110202328

来源: mdpi

【 摘 要 】

Bitter Melon (Momordica charantia) is a widely used traditional remedy for hyperglycemia. While the medicinal properties of this plant have been studied extensively using in vitro and animal models, the clinical efficacy and safety in humans is largely unknown. This review discusses the benefits and limitations of bitter melon supplementation in the context of epidemic levels of insulin resistance and pre-diabetes throughout the world.

【 授权许可】

CC BY   
© 2014 by the authors; licensee MDPI, Basel, Switzerland.